st7 general paediatrics
play

ST7 General Paediatrics RHSC Edinburgh Guideline overview What are - PowerPoint PPT Presentation

David Beattie ST7 General Paediatrics RHSC Edinburgh Guideline overview What are we auditing? Results What can we take from this? Questions/ discussion Dr Lizzie Bayman proposed guideline to be used locally To


  1. David Beattie ST7 General Paediatrics RHSC Edinburgh

  2.  Guideline overview  What are we auditing?  Results  What can we take from this?  Questions/ discussion

  3.  Dr Lizzie Bayman – proposed guideline to be used locally  To guide identification and assessment of short stature ◦ Primary care and general paediatrics ◦ Tertiary paediatric endocrinologists considering start of GH therapy  When to refer to tertiary services for short stature ◦ If meet any of 5 criteria  Framework of preliminary investigations for short stature

  4.  Severe short stature – height <0.4 th centile  Height 2 centiles or more below mid-parental height  Height below 2 nd centile and a height velocity over 1 year less than 25 th centile  2 years of age or more and crossing more than 1 height centile in a year  In absence of short stature, a height velocity less than 3 rd centile over 1 year or less than 10 th centile sustained over 2 years

  5.  FBC  U and E  LFT  Ferritin  Vitamin D  Coeliac screen  IGF-1  Karyotype  Bone age x-ray  If pubertal age/ signs of puberty: LH, FSH Females - Oestradiol Males - Testosterone

  6.  Aim – To establish what our currently practice is and whether children requiring growth hormone would be picked up using this proposed new guideline  Method ◦ Retrospective analysis of 25 insulin tolerance tests (ITT) performed in NHS Lothian  Lothian – in context of blood glucose <2.2 or 50% reduction from baseline: Peak GH >5ug/L: pass ITT  Peak GH 2-5ug/L: growth hormone deficiency  Peak GH <2ug/L: severe growth hormone deficiency  ◦ Height, height velocity and MPH were calculated and compared against guideline criteria of when to refer ◦ Which investigations had been performed prior to ITT

  7.  25 ITT ◦ 17 male ◦ 8 female ◦ 2 excluded as not GH naive  Data from 23 patients analysed ◦ NHS Lothian n= 20 ◦ NHS Fife n = 1 ◦ NHS Tayside n = 1 ◦ NHS Highland n = 1 ◦ NHS D&G n = 2

  8. 4 3 2 1 0 Number of criteria

  9. HV <10th centile for 2 years/ <3rd centile for 1 year >2 years of age and crossing >1 height centile in 1 year <2nd centile and HV (1 year) <25th centile >2 centiles below MPH <0.4th centile 0 2 4 6 8 10 12 14 16 Number of patients

  10. 4 3 2 1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Height<0.4th centile >2 centiles below MPH Height <2nd centile + HV (1 year) <25th centile >2 years of age and crossing >1 height centile in 1 year HV 10th centile for 2 years/ <3rd centile for over 1 year (in absence of short stature)

  11. 4 3 2 1 0 1 2 3 4 5 6 7 8 Height<0.4th centile >2 centiles below MPH Height <2nd centile + HV (1 year) <25th centile

  12. 6 5 4 3 2 1 0 >+2 SD +1+2 SD 0+1 SD 0-1 SD -1-2 SD >-2 SD Passed ITT Failed ITT

  13. 20 15 10 5 0

  14.  Results suggests that children who had ITT and needed GH would have been picked up using this guideline ◦ All 15 needing growth hormone met at least 1 criteria ◦ 11 of 15 had only 1 criteria suggesting the differing criteria are worthwhile  0 patients met “crossing >1 height centile in 1 year”  Baseline investigations already being done (Vitamin D, coeliac, ferritin and karyotype less regular)  Difficulty in availability of karyotype results

  15.  Retrospective audit: Extract data from CAS on last 50 referrals for short stature/ slow growth against same criteria/ investigations  Prospective audit using guideline: primary care/ general paediatric clinic referrals to tertiary endocrine services for short stature

  16.  Lizzie Bayman  Jennifer Roach  Mike Crane  Louise Bath  Clare Webster  Anthony Tasker  Stuart Henderson  Raj Shyam

  17. Any questions?

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend